Eliminating pharmaceutical impurities: Recent advances in detection techniques
- PMID: 21061235
Eliminating pharmaceutical impurities: Recent advances in detection techniques
Abstract
The elimination of organic impurities to produce highly pure drug substances is an important goal of process chemistry. For the detection of general impurities, hyphenated techniques (eg, liquid chromatography-mass spectrometry [LC-MS]) play a critical role in rapid structural identification (qualitative detection) and in understanding the mechanisms of formation of the impurities, enabling informed decisions to control and eliminate the impurities resulting from the chemical process where possible. Concern regarding genotoxic impurities (GTIs), which must typically be controlled at low parts-per-million limits, continues to increase, and significant advances have been achieved in recent years for the selective and sensitive quantitation (quantitative detection) of such impurities. Conventional detection techniques, such as ultraviolet (UV) detection, are often inadequate for the detection of potentially minute quantities of GTIs; therefore, various advanced MS-based detection strategies, either stand-alone or in conjunction with chemical approaches, are playing an increasing role in this field. The primary aim of this review is to highlight recent advances in qualitative and quantitative detection of impurities at trace levels, with a particular focus on GTIs.
Similar articles
-
Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective.J Pharm Biomed Anal. 2011 Jun 25;55(4):662-7. doi: 10.1016/j.jpba.2010.11.039. Epub 2010 Dec 3. J Pharm Biomed Anal. 2011. PMID: 21193280 Review.
-
Recent advances in trace analysis of pharmaceutical genotoxic impurities.J Pharm Biomed Anal. 2010 Apr 6;51(5):999-1014. doi: 10.1016/j.jpba.2009.11.009. Epub 2009 Nov 13. J Pharm Biomed Anal. 2010. PMID: 20022442 Review.
-
Overall impact of the regulatory requirements for genotoxic impurities on the drug development process.Eur J Pharm Sci. 2011 May 18;43(1-2):1-15. doi: 10.1016/j.ejps.2011.03.004. Epub 2011 Mar 21. Eur J Pharm Sci. 2011. PMID: 21420491 Review.
-
Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process.J Pharm Biomed Anal. 2009 Sep 8;50(2):144-50. doi: 10.1016/j.jpba.2009.04.002. Epub 2009 Apr 10. J Pharm Biomed Anal. 2009. PMID: 19427156
-
Pharmaceutical impurities and degradation products: uses and applications of NMR techniques.J Pharm Biomed Anal. 2014 Dec;101:102-22. doi: 10.1016/j.jpba.2014.04.016. Epub 2014 Apr 24. J Pharm Biomed Anal. 2014. PMID: 24853620 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical